The Impact Of Altitude Changes On CardioMEMS Readings

Omar Al-Abboud,Farah Al-Saffar,Aasim Afzal
DOI: https://doi.org/10.1016/j.cardfail.2023.10.264
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Introduction Heart failure is a chronic and progressive condition that requires monitoring and adjustment of medications to prevent exacerbations. The CardioMEMS System is a wireless pulmonary artery pressure monitoring device that is approved for use in patients with heart failure NYHA Class II or Class III with one heart failure hospitalization within 12 months. However, discrepancies in CardioMEMS home readings compared with in-hospital measurements can occur and may lead to unnecessary medication changes. Our case highlights the need to factor in altitude changes as a potential cause of error in CardioMEMS readings across different locations. Case Presentation A 58-year-old female with a history of heart failure received an implanted CardioMEMS device to monitor her PA pressures. She presented to our clinic with elevated PA pressures, after adjusting her outpatient medications based on the premise of her being volume overloaded. However, subsequent right heart catheterization (RHC) to calibrate her device showed that she was euvolemic with normal filling pressures. Recalibration was done, but the PA pressures transmitted by the device were still similar while at our facility in Dallas. Upon questioning, the patient disclosed living in Los Alamos, NM. We found that the PA diastolic pressure was 16 mmHg at the hospital (Dallas), but 30 mmHg at the patient's home in Los Alamos (7300 ft). The CardioMEMS engineering staff confirmed our suspicion, and we made a note in Merlin for future reference and avoiding confusion. Discussion The CardioMEMS HF System is a valuable tool for monitoring PA pressures in heart failure patients, but altitude changes can lead to discrepancies in readings. The device is implanted in the pulmonary artery and wirelessly transmits data on PA pressures and heart rate. However, discrepancies can occur due to changes in elevation between the initial baseline calibration and subsequent measurements. The device's accuracy can be influenced by significant elevation changes (increasing 2 mmHg per 1000 ft above sea-level) between the baseline calibration and later measurements. Conclusion In conclusion, it is essential to keep in mind patient details such as residential location and difference from the location of implantation to prevent confusion. If discrepancies occur, notify patients about the impact of altitude changes and ensure that daily measurements occur in the same location. By doing so, we can ensure that the readings are accurate and avoid any unnecessary changes in medication that could harm the patient by preventing volume depletion due to falsely elevated readings. Having a good understanding of the impact of altitude changes is vital to interpret device data accurately and manage heart failure patients optimally across healthcare teams.
cardiac & cardiovascular systems
What problem does this paper attempt to address?